7.15
price down icon1.52%   -0.11
after-market アフターアワーズ: 7.19 0.04 +0.56%
loading
前日終値:
$7.26
開ける:
$7.3
24時間の取引高:
6.52M
Relative Volume:
0.80
時価総額:
$1.16B
収益:
$847.25M
当期純損益:
$-284.86M
株価収益率:
-3.1223
EPS:
-2.29
ネットキャッシュフロー:
$-112.35M
1週間 パフォーマンス:
+3.32%
1か月 パフォーマンス:
+11.54%
6か月 パフォーマンス:
-13.86%
1年 パフォーマンス:
-59.74%
1日の値動き範囲:
Value
$7.105
$7.44
1週間の範囲:
Value
$6.89
$7.47
52週間の値動き範囲:
Value
$5.01
$23.86

Novavax Inc Stock (NVAX) Company Profile

Name
名前
Novavax Inc
Name
セクター
Healthcare (1170)
Name
電話
240-268-2000
Name
住所
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
職員
1,992
Name
Twitter
@novavax
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
NVAX's Discussions on Twitter

NVAX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NVAX
Novavax Inc
7.15 1.20B 847.25M -284.86M -112.35M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 40.54M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 65.13B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ATHE
Alterity Therapeutics Ltd Adr
4.75 63.36M 0 0 0 0.00
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
305.31 37.83B 2.35B -269.70M -75.39M -2.09

Novavax Inc Stock (NVAX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-28 開始されました BTIG Research Buy
2024-07-30 ダウングレード JP Morgan Neutral → Underweight
2024-05-10 アップグレード BofA Securities Underperform → Neutral
2024-05-10 アップグレード JP Morgan Underweight → Neutral
2023-08-09 アップグレード B. Riley Securities Neutral → Buy
2023-04-20 ダウングレード TD Cowen Outperform → Market Perform
2023-03-01 ダウングレード B. Riley Securities Buy → Neutral
2023-01-09 繰り返されました B. Riley Securities Buy
2022-12-30 繰り返されました H.C. Wainwright Buy
2022-12-02 開始されました Jefferies Hold
2022-09-22 ダウングレード JP Morgan Neutral → Underweight
2022-05-20 開始されました BofA Securities Underperform
2022-02-23 繰り返されました B. Riley Securities Buy
2022-02-22 再開されました Jefferies Buy
2022-01-21 開始されました Cowen Outperform
2021-05-12 ダウングレード JP Morgan Overweight → Neutral
2020-12-14 開始されました Jefferies Buy
2020-08-06 繰り返されました H.C. Wainwright Buy
2020-08-05 アップグレード JP Morgan Neutral → Overweight
2020-08-05 ダウングレード Ladenburg Thalmann Neutral → Sell
2020-07-16 繰り返されました H.C. Wainwright Buy
2020-07-08 ダウングレード Ladenburg Thalmann Buy → Neutral
2020-06-29 繰り返されました B. Riley FBR Buy
2020-06-29 繰り返されました H.C. Wainwright Buy
2020-06-05 アップグレード JP Morgan Underweight → Neutral
2020-05-28 繰り返されました B. Riley FBR Buy
2020-05-12 繰り返されました H.C. Wainwright Buy
2020-04-30 繰り返されました H.C. Wainwright Buy
2019-11-27 再開されました B. Riley FBR Buy
2019-08-14 繰り返されました H.C. Wainwright Buy
2019-02-28 ダウングレード Piper Jaffray Overweight → Underweight
2018-12-18 開始されました Ladenburg Thalmann Buy
2018-12-11 開始されました Oppenheimer Outperform
2018-11-26 アップグレード Piper Jaffray Neutral → Overweight
2018-09-21 アップグレード JP Morgan Underweight → Overweight
2018-03-29 アップグレード Seaport Global Securities Neutral → Buy
すべてを表示

Novavax Inc (NVAX) 最新ニュース

pulisher
Jun 02, 2025

Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals - Benzinga

Jun 02, 2025
pulisher
May 31, 2025

Novavax (NVAX) Sees Surge in Bullish Option Activity | NVAX Stoc - GuruFocus

May 31, 2025
pulisher
May 30, 2025

US CDC continues to recommend COVID vaccines for children, contradicts Kennedy - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Novavax (NVAX) Sees Surge in Bullish Option Activity | NVAX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risks - Benzinga

May 30, 2025
pulisher
May 29, 2025

Novavax to Participate in Upcoming Investor Conferences - Quantisnow

May 29, 2025
pulisher
May 29, 2025

Novavax to Participate in Upcoming Investor Conferences | NVAX S - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Novavax Announces June Presentations at Jefferies and Goldman Sachs Conferences | NVAX Stock News - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 28, 2025
pulisher
May 28, 2025

Novavax eliminates COO role, parts ways with longtime exec amid business model shift - The Business Journals

May 28, 2025
pulisher
May 28, 2025

(NVAX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 28, 2025
pulisher
May 27, 2025

Novavax Eliminates COO Position, Trizzino to Consult - TipRanks

May 27, 2025
pulisher
May 27, 2025

Novavax IncEliminates COO Position, Terminates John TrizzinoSEC Filing - marketscreener.com

May 27, 2025
pulisher
May 26, 2025

Here's Why Novavax (NVAX) is a Strong Momentum Stock - Yahoo Finance

May 26, 2025
pulisher
May 26, 2025

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 26, 2025
pulisher
May 25, 2025

Novavax COVID-19 vaccine approved by the FDA - MSN

May 25, 2025
pulisher
May 24, 2025

Gaithersburg-Based Novavax Receives FDA Approval for COVID-19 Vaccine for High-Risk Groups - The MoCo Show -

May 24, 2025
pulisher
May 24, 2025

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News - MSN

May 24, 2025
pulisher
May 24, 2025

Novavax Target of Unusually High Options Trading (NASDAQ:NVAX) - Defense World

May 24, 2025
pulisher
May 23, 2025

BofA Reiterates Hold Rating on Novavax (NVAX) Stock - MSN

May 23, 2025
pulisher
May 23, 2025

Analysts Think These Stocks Could More Than Double in Value - MarketBeat

May 23, 2025
pulisher
May 23, 2025

Rx Rundown: BioMarin, Novavax, CellCentric and more - Medical Marketing and Media

May 23, 2025
pulisher
May 23, 2025

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of “Hold” by Analysts - Defense World

May 23, 2025
pulisher
May 22, 2025

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine - MSN

May 22, 2025
pulisher
May 22, 2025

NVAX July 3rd Options Begin Trading - Nasdaq

May 22, 2025
pulisher
May 21, 2025

New Vaccine Framework Avoided Worst-Case Scenario, Analysts Say - insights.citeline.com

May 21, 2025
pulisher
May 21, 2025

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli (NASDAQ:NVAX) - Seeking Alpha

May 21, 2025
pulisher
May 20, 2025

Novavax Soars After Covid Vaccine Secures Full FDA Approval - MSN

May 20, 2025
pulisher
May 20, 2025

Novavax Stock (NVAX) Shoots 15% Higher as Covid Vaccine Jab Gets FDA Green Light - The Globe and Mail

May 20, 2025
pulisher
May 20, 2025

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Novavax, Inc. (NASDAQ:NVAX) Shares Fly 29% But Investors Aren't Buying For Growth - simplywall.st

May 20, 2025
pulisher
May 20, 2025

Novavax’s COVID-19 Vaccine Label Narrowed After Political Officials Intervened - insights.citeline.com

May 20, 2025
pulisher
May 20, 2025

Dow Surges Over 100 Points Despite Moody's US Downgrade: Fear Index Remains In 'Greed' Zone - Benzinga

May 20, 2025
pulisher
May 20, 2025

US Markets Show Mixed Signals Amid Rating Downgrades And Rising Earnings - Finimize

May 20, 2025
pulisher
May 20, 2025

Novavax Receives FDA Approval for Nuvaxovid Vaccine for High-Risk Populations - madisongraph.com

May 20, 2025
pulisher
May 19, 2025

Novavax gets FDA nod for Nuvaxovid vaccine in high-risk groups By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

JPMorgan maintains Novavax stock Underweight with $7 target By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions - MSN

May 19, 2025
pulisher
May 19, 2025

Third COVID Vaccine Gets Approved for Adults 65 and Over - AARP

May 19, 2025
pulisher
May 19, 2025

These Stocks Moved the Most Today: Nvidia, Tesla, UnitedHealth, JPMorgan, SMCI, Palantir, Novavax, and More - Barron's

May 19, 2025
pulisher
May 19, 2025

With FDA vaccine nod, Novavax takes ACIP of new COVID-19 rules - BioWorld MedTech

May 19, 2025
pulisher
May 19, 2025

FDA Approval Boosts Novavax (NVAX) with $200M Milestone | NVAX S - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Novavax, Shake Shack, solar stocks: Trending Tickers - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Novavax gets FDA nod for Nuvaxovid vaccine in high-risk groups - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday? - Benzinga

May 19, 2025
pulisher
May 19, 2025

US Approves Novavax Covid Jab After Delay, Adds Restrictions - Barron's

May 19, 2025
pulisher
May 19, 2025

Novavax secures FDA approval for COVID-19 vaccine - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Novavax secures FDA approval for COVID-19 vaccine By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

FDA approves Novavax COVID vaccine with new conditions - Reuters

May 19, 2025
pulisher
May 19, 2025

Novavax’s COVID vaccine gets FDA approval, but with limits - BioPharma Dive

May 19, 2025

Novavax Inc (NVAX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
biotechnology ONC
$258.27
price up icon 2.60%
$111.14
price down icon 3.89%
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
大文字化:     |  ボリューム (24 時間):